NCT06381154 2026-01-30
Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer
Mayo Clinic
Phase 2 Recruiting
Clinical Trials
7 trialsNCT03033225 2025-07-30
Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 Study
Mayo Clinic
Phase 2 Completed
NCT05386056 2022-11-28
Pembrolizumab and Photodynamic Therapy in Previously Treated Metastatic Esophageal Squamous Cell Carcinoma
Peking University
Phase 2 Unknown
NCT00217087 2015-12-24
Endoscopic Therapy of Early Cancer in Barretts Esophagus
Mayo Clinic
Phase 2 Completed
NCT00713687 2012-08-10
GemOx-PDT
Technical University of Munich
Phase 2 Withdrawn
NCT00083785 2007-04-11
Study of the Litxâ„¢ System Combined With Chemotherapy in Patients With Colorectal Liver Metastases
Light Sciences LLC
Phase 2 Completed
NCT00068068 2006-09-19
Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver Metastases
Light Sciences LLC
Phase 2 Completed